a.m. Eastern on the same day, Magellan's management will host a conference call and webcast to discuss earnings and other information.

More Bonds of Magellan Midstream Partners L.P. Moody’s Daily Credit Risk Score About the Magellan Midstream Partners L.P.-Bond (US559080AM85) The Magellan Midstream Partners L.P.-Bond has a maturity ...

A company that makes tests for lead poisoning has agreed to resolve criminal charges that it concealed for years a malfunction that resulted in inaccurately low results. It's the latest in a ...

Feb 27 (Reuters) - A former executive at Magellan Diagnostics has agreed to plead guilty to concealing from regulators that the company had discovered a malfunction in its lead-testing devices that ...

The problems at Magellan Diagnostics in Billerica first became public in 2017 when the Food and Drug Administration warned that the company, self-marketed as “the most trusted name in lead testing,” ...

Three former leaders from Magellan Diagnostics are facing a flurry of federal charges stemming from sales of inaccurate blood-based lead tests between 2013 and 2017. The executives were arrested ...

Magellan Midstream Partners, L.P. (NYSE: MMP) has had a relatively quiet first half of 2017 since it didn't announce any major acquisitions or new growth projects. That said, what the company has ...

Magellan Diagnostics, fined $42 million for selling faulty lead tests between 2013 and 2017, pleads guilty By John R. Ellement Globe Staff,Updated October 11, 2024, 2:00 p.m.

Three former executives at Magellan Diagnostics have pleaded guilty to concealing a device malfunction that led to inaccurate lead level tests in thousands of patients, many of them children. The ...

BOSTON, March 4 (Reuters) - Magellan Diagnostics' former chief operating officer has agreed to plead guilty to U.S. charges that he helped distribute the company's lead-testing devices without ...